Results 151 to 160 of about 4,283,017 (213)

[The life path of Irma Carrica: An approach to the political and health debates of the 1960s and 1970s using the biographical method]. [PDF]

Salud Colect
Vigo Deandreis MG, Fonseca M.
europepmc   +1 more source

Transmisión Crediticia, Liquidez y Capital Bancario en Colombia (Credit Transmission, Liquidity, and Bank Capital in Colombia)

, 2021
Clavijo S.
europepmc   +1 more source

The effect of an educational intervention for university students on violence against the elderly using gamification: a non-randomized clinical trial. [PDF]

Rev Lat Am Enfermagem
Vernasque JRDS, Alarcon MFS, Bonfim D, Rodrigues PS, Chagas EFB, Marin MJS.   +5 more
europepmc   +1 more source

Practice environment and burnout in intensive care units: is job satisfaction a mediator in this relationship? [PDF]

Rev Lat Am Enfermagem
Furlan JADS, Guirardello EB.
europepmc   +1 more source

Antecedentes al actual modelo de gobierno corporativo en los Estados Unidos de América: de 1934- a 2014

, 2018
In this work we shall make a summary of the history of the corporate Governance, since the enactment of the SEC, till nowadays. We shall see the difficult path that the minority shareholder has got to follow, to the proper exercise of his rights, first against the power-full management of the company, and later to the institutional investors.
openaire   +1 more source

[Narrative objects of science: From industrialization to the cobotization of the interpretive experience]. [PDF]

Salud Colect
Martinovich V.
europepmc   +1 more source

Dezoito anos em dois dias

, 2021
Aita Schmitz CA, Rodrigues Gonçalves M, Nunes Umpierre R, Martins Costa M, Harzheim E, Souza da Silva R, Goulart Molina-Bastos C, Ambrosini Mendonça MV, Katz N.   +8 more
europepmc   +1 more source

[Pharmaceutical services in expanded access, compassionate use, and post-trial access: the perspective of clinical researchers]. [PDF]

Cad Saude Publica
Silva MBFCD, Silva CFD, Silva MJSD.
europepmc   +1 more source

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial. [PDF]

Nat Commun
Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB, Immune Assays Team, Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team, United States Government (USG)/CoVPN Biostatistics Team.   +60 more
europepmc   +1 more source